190 related articles for article (PubMed ID: 9448142)
1. An experimental model of chronic renal allograft rejection in the rat using triple drug immunosuppression.
Soots A; Lautenschlager I; Krogerus L; Saarinen O; Ahonen J
Transplantation; 1998 Jan; 65(1):42-6. PubMed ID: 9448142
[TBL] [Abstract][Full Text] [Related]
2. Effect of cytomegalovirus on an experimental model of chronic renal allograft rejection under triple-drug treatment in the rat.
Lautenschlager I; Soots A; Krogerus L; Kauppinen H; Saarinen O; Bruggeman C; Ahonen J
Transplantation; 1997 Aug; 64(3):391-8. PubMed ID: 9275101
[TBL] [Abstract][Full Text] [Related]
3. Development of chronic allograft rejection and arterial hypertension in Brown Norway rats after renal transplantation.
Vaskonen T; Mervaala E; Nevala R; Soots A; Krogerus L; Lähteenmäki T; Karppanen H; Vapaatalo H; Ahonen J
Blood Press; 2000; 9(2-3):162-8. PubMed ID: 10855741
[TBL] [Abstract][Full Text] [Related]
4. An experimental model of chronic kidney allograft rejection under triple-drug treatment in the rat.
Soots A; Lautenschlager I; Krogerus L; Saarinen O; Ahonen J
Transplant Proc; 1997 Nov; 29(7):3152. PubMed ID: 9365704
[No Abstract] [Full Text] [Related]
5. Triple drug immunosuppression significantly reduces aortic allograft arteriosclerosis in the rat.
Lemström KB; Räisänen-Sokolowski AK; Häyry PJ; Koskinen PK
Arterioscler Thromb Vasc Biol; 1996 Apr; 16(4):553-64. PubMed ID: 8624778
[TBL] [Abstract][Full Text] [Related]
6. Marrow Mesenchymal Stem Cells Effectively Reduce Histologic Changes in a Rat Model of Chronic Renal Allograft Rejection.
Yu P; Wang Z; Liu Y; Xiao Z; Guo Y; Li M; Zhao M
Transplant Proc; 2017 Nov; 49(9):2194-2203. PubMed ID: 29149982
[TBL] [Abstract][Full Text] [Related]
7. The effect of leflunomide analogue FK778 on development of chronic rat renal allograft rejection and transforming growth factor-BETA expression.
Rintala JM; Savikko J; Rintala SE; von Willebrand E
Transplant Proc; 2006 Dec; 38(10):3239-40. PubMed ID: 17175234
[TBL] [Abstract][Full Text] [Related]
8. FK778 ameliorates post-transplant expression of fibrogenic growth factors and development of chronic rejection changes in rat kidney allografts.
Rintala JM; Savikko J; Rintala SE; von Willebrand E
Nephrol Dial Transplant; 2008 Nov; 23(11):3446-55. PubMed ID: 18558624
[TBL] [Abstract][Full Text] [Related]
9. Chronic rejection of rat renal allograft. I. Histological differentiation between chronic rejection and cyclosporin nephrotoxicity.
Yilmaz S; Taskinen E; Paavonen T; Mennander A; Häyry P
Transpl Int; 1992 May; 5(2):85-95. PubMed ID: 1627245
[TBL] [Abstract][Full Text] [Related]
10. A rat model of chronic allograft liver rejection.
Gao LH; Zheng SS; Zhu YF; Wan YL; Wei GQ; Qian SK; Jiang WJ
Transplant Proc; 2005 Jun; 37(5):2327-32. PubMed ID: 15964409
[TBL] [Abstract][Full Text] [Related]
11. Chronic rejection of renal allografts with four immunosuppressive regimens.
Isoniemi H; Ahonen J; Krogerus L; Eklund B; Höckerstedt K; Salmela K; Häyry P
Transplant Proc; 1992 Dec; 24(6):2716-7. PubMed ID: 1465912
[No Abstract] [Full Text] [Related]
12. Cytomegalovirus increases collagen synthesis in chronic rejection in the rat.
Inkinen K; Soots A; Krogerus L; Bruggeman C; Ahonen J; Lautenschlager I
Nephrol Dial Transplant; 2002 May; 17(5):772-9. PubMed ID: 11981062
[TBL] [Abstract][Full Text] [Related]
13. Chronic allograft nephropathy is prevented by inhibition of platelet-derived growth factor receptor: tyrosine kinase inhibitors as a potential therapy.
Savikko J; Taskinen E; Von Willebrand E
Transplantation; 2003 Apr; 75(8):1147-53. PubMed ID: 12717194
[TBL] [Abstract][Full Text] [Related]
14. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.
Morrissey PE; Gohh R; Shaffer D; Crosson A; Madras PN; Sahyoun AI; Monaco AP
Transplantation; 1997 Mar; 63(6):845-8. PubMed ID: 9089224
[TBL] [Abstract][Full Text] [Related]
15. A chronic renal rejection model with a fully MHC-mismatched rat strain combination under immunosuppressive therapy.
Hanaoka K; Kawato Y; Kubo K; Nakanishi T; Maeda M; Nakamura K; Hirose J; Noto T; Fukahori H; Fujikawa A; Miyoshi S; Takakura S; Morokata T; Higashi Y
Transpl Immunol; 2016 Sep; 38():19-26. PubMed ID: 27545900
[TBL] [Abstract][Full Text] [Related]
16. The effect of a new immunosuppressive drug, brequinar sodium, on heart, liver, and kidney allograft rejection in the rat.
Cramer DV; Chapman FA; Jaffee BD; Jones EA; Knoop M; Hreha-Eiras G; Makowka L
Transplantation; 1992 Feb; 53(2):303-8. PubMed ID: 1531394
[TBL] [Abstract][Full Text] [Related]
17. The utility of 6-month protocol renal biopsy under modern immunosuppression.
Yango A; Gohh R; Wang LJ; Morrissey P; Shih M; Lowery K; Charpentier K; Gautam A; Mendonca C; Kumar S; Dworkin L; Monaco A
Clin Nephrol; 2008 Dec; 70(6):490-5. PubMed ID: 19049705
[TBL] [Abstract][Full Text] [Related]
18. Sirolimus attenuates chronic allograft nephropathy in an experimental rat kidney transplantation model.
Savikko J; von Willebrand E
Transplant Proc; 2006 Oct; 38(8):2699-700. PubMed ID: 17098043
[TBL] [Abstract][Full Text] [Related]
19. Long-term consequences of different immunosuppressive regimens for renal allografts.
Isoniemi HM; Ahonen J; Tikkanen MJ; von Willebrand EO; Krogerus L; Eklund BH; Höckerstedt KV; Salmela KE; Häyry PJ
Transplantation; 1993 Mar; 55(3):494-9. PubMed ID: 8456467
[TBL] [Abstract][Full Text] [Related]
20. Tacrolimus rescue for resistant rejection, chronic rejection, and immunoglobulin A nephropathy of renal allografts under primary cyclosporine A immunosuppression.
Manu MA; Tanabe K; Ishikawa N; Tokumoto T; Oshima T; Shinmura H; Harano M; Otsubo S; Inui M; Kanematsu A; Fuchinoue S; Toma H
Transplant Proc; 1999 Nov; 31(7):2853-5. PubMed ID: 10578313
[No Abstract] [Full Text] [Related]
[Next] [New Search]
